Učitavanje...

Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL

The hypothesis that raising high-density lipoprotein cholesterol (HDL-C) levels could improve the risk for cardiovascular disease (CVD) is facing challenges. There is multitudinous clear clinical evidence that the latest failures of HDL-C-raising drugs show no clear association with risks for CVD. A...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Peiqiu Cao, Haitao Pan, Tiancun Xiao, Ting Zhou, Jiao Guo, Zhengquan Su
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2015-07-01
Serija:International Journal of Molecular Sciences
Teme:
HDL
Online pristup:http://www.mdpi.com/1422-0067/16/8/17245
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!